Efficacy and tolerability of reboxetine compared with imipramine in a double-blind study in patients suffering from major depressive episodes

European Neuropsychopharmacology

Volumn 7, Issue SUPPL. 1, 1997, Pages

  Berzewski, H ^a   Van Moffaert, M ^a   Gagiano, C A ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Major depression; Reboxetine; Selective noradrenaline reuptake inhibitors (NARIs)

Indexed keywords

IMIPRAMINE; NORADRENALIN UPTAKE INHIBITOR; PLACEBO; REBOXETINE;

ADULT; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SELECTIVITY; DRUG TOLERABILITY; FEMALE; HAMILTON SCALE; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MELANCHOLIA; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREMOR; XEROSTOMIA;

EID: 0030909893     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(97)00418-5     Document Type: Conference Paper

References (23)

1. American Psychiatric Association. (1987) Mood disorders. In: Diagnostic and Statistical Manual of Mental Disorders. Third edition revised, American Psychiatric Association, Washington DC.
2. American Psychiatric Association. (1994) Mood disorders. In: Diagnostic and Statistical Manual of Mental Disorders. Fourth edition, American Psychiatric Association, Washington DC.
3. J. Angst P. Bech P. Boyer J. Bruinvels R. Engel H. Helmchen H. Hippius O. Lingjaerde G. Racagni B. Saletu G. Sedvall J.T. Silverstone C.N. Stefanis K. Stoll B. Woggon Consensus conference on the methodology of clinical trials of antide-pressants, Zurich, March 1988: Report of the Consensus Committee Pharmacopsychiatry 22 1989 3 7
4. M. Asberg S.A. Montgomery C. Perris D. Schalling G. Sedvall A comprehensive psychopathological psychiatric rating scale (CPRS) Acta. Psychiatr. Scand. 271 1978 5 27
5. G. Beaumont The toxicity of antidepressants Br. J. Psychiatry 154 1989 454 458
6. C. Chuang-Stein Summarizing laboratory data with different reference ranges in multi-center clinical trials Drug Inf. J. 26 1992 77 84
7. J. Cookson Side-effects of antidepressants Br. J. Psychiatry 163 Suppl. 20 1993 20 24
8. CPMP Guidelines on psychotropic drugs for the EC Eur. Neuropsychopharmacol. 4 1994 61 77
9. J.L. Fleiss Statistical Methods for Rates and Proportions 1973 John Wiley and Sons New York
10. J.L. Gill Design and Analysis of Experiments in the Animal and Medical Sciences 1978 The Iowa State University Press Ames, Iowa, USA
11. Guy, W. (1976) ECDEU Assessment Manual for Psychopharmacology. US Department of Health, Education and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, Rockville, Maryland.
12. M. Hamilton A rating scale for depression J. Neurol. Neurosurg. Psychiatry 23 1960 56 62
13. M. Hollander D.A. Wolfe Nonparametric Statistical Methods 1973 John Wiley and Sons New York
14. J.D. Kalbfleisch R.L. Prentice The Statistical Analysis of Failure Time Data 1980 John Wiley and Sons New York
15. J.H. Kocsis J.L. Croughan M.M. Katz T.P. Butler S. Secunda C.L. Bowden J.M. Davis Response to treatment with antidepressants of patients with severe or moderate nonpsychotic depression and of patients with psychotic depression Am. J. Psychiatry 147 1990 621 624
16. G. Laakmann Antidepressants H. Hippius G. Winokur Psychopharmacology 1-Part 2: Clinical Psychopharmacology 1983 Excerpta Medica Amsterdam 83 86
17. P. Melloni G. Carniel A. Della Torre A. Bonsignori M. Buonamici O. Pozzi S. Ricciardi A.C. Rossi Potential antidepressant agents. ce-Aryloxy-benzyl derivatives of ethanolamine and morpholine Eur. J. Med. Chem-Chim. Ther. 19 1984 235 242
18. S.A. Montgomery M.A. Asberg New depression scale designed to be sensitive to change Br. J. Psychiatry 134 1979 382 389
19. K.E. Peace Biopharmaceutical Statistics for Drug Development 1988 Marcel Dekker New York
20. M. Riva N. Brunello A.C. Rovescalli R. Galimberti N. Carfagna P. Carminati O. Pozzi S. Ricciardi R. Roncucci A. Rossi G. Racagni Effect of reboxetine, a new antidepressant drug, on the central noradrenergic system: behavioural and biochemical studies J. Drug. Dev. 1 1989 243 253
21. P. Stark C.D. Hardison A review of multicentre controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder. J. Clin. Psychiatry 46 3, Sec 2 1985 53 58
22. B. Spilker Guide to Clinical Studies and Developing Protocols 1984 Raven Press New York
23. N. Theofilopoulos G. McDade E. Szabadi C.M. Bradshaw Effects of reboxetine and desipramine on the kinetics of the pupillary light reflex Br. J. Clin. Pharmacol. 39 1995 251 255